Cybin (HELP) Other financing activities (2020 - 2025)
Cybin (HELP) posted quarterly Other financing activities of $28.0 million for Q4 2025, up 60374.84% year-on-year from N/an in Q4 2024, and up 123.64% on a QoQ basis from -$118.6 million in Q3 2025.
Cybin (HELP) Other financing activities (2020 - 2025) Analysis & Trends
Cybin (HELP) has reported Other financing activities for 6 consecutive years, with $28.0 million the latest figure, recorded in Q4 2025.
- Quarterly Other financing activities rose 60374.84% year-over-year to $28.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28.1 million (up 87.3% YoY) and the FY2023 annual result came in at $45621.6, down 37.44% from the prior year.
- Other financing activities advanced to $28.0 million in Q4 2025 per HELP's latest filing, from -$118.6 million in the prior quarter.
- Over the last five years, Other financing activities for HELP reached as high as $118.7 million in Q2 2025 and fell as low as -$118.6 million in Q3 2025.
- A 5-year average of $12.5 million and a median of $6.5 million in 2023 frame the typical range for Other financing activities.
- The largest YoY upside for Other financing activities was 109051.78% in 2025 against a maximum downside of 57700.8% in 2025.
- Year by year, Other financing activities stood at $50.4 million in 2021, then plunged by 110.85% to -$5.5 million in 2022, then soared by 380.36% to $15.3 million in 2023, then slumped by 100.3% to -$46530.2 in 2024, then surged by 60374.84% to $28.0 million in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered $28.0 million, -$118.6 million, and $118.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.05 Mn |
| Dec 31, 2025 | 28.05 Mn |
| Sep 30, 2025 | -118.64 Mn |
| Sep 30, 2025 | -118.64 Mn |
| Jun 30, 2025 | 118.69 Mn |
| Jun 30, 2025 | 118.69 Mn |
| Dec 31, 2024 | -46,530.19 |
| Dec 31, 2024 | -46,530.19 |
| Sep 30, 2024 | -205,254.95 |
| Sep 30, 2024 | -205,254.95 |
| Jun 30, 2024 | -108,939.94 |
| Jun 30, 2024 | -108,939.94 |
| Dec 31, 2023 | 15.34 Mn |
| Dec 31, 2023 | 15.34 Mn |
| Sep 30, 2023 | 6.54 Mn |
| Sep 30, 2023 | 6.54 Mn |
| Jun 30, 2023 | 6.96 Mn |
| Jun 30, 2023 | 6.96 Mn |
| Feb 28, 2023 | -16.65 Mn |
| Feb 28, 2023 | -16.65 Mn |